<DOC>
	<DOCNO>NCT02262611</DOCNO>
	<brief_summary>Study obtain long-term data effect , safety tolerability routine medical practice investigate potential telmisartan prevent secondary organ damage</brief_summary>
	<brief_title>Post Marketing Surveillance Study Rehabilitation Clinics ( Cardio , Nephro , Diabetes , Pulmo )</brief_title>
	<detailed_description />
	<mesh_term>Telmisartan , hydrochlorothiazide drug combination</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Adult patient gender age &gt; =18 admit hospital due insufficiently control essential hypertension . No additional selection criterion consider . Treatment discretion physician follow summary product information Micardis® MicardisPlus®</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>